HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia.

AbstractOBJECTIVES:
Hypothermia is still unproven as beneficial treatment in human stroke, although in animal models, conditioning the brain with hypothermia has induced tolerance to insults. Here, we delineate the feasibility of drug-induced mild hypothermia in reducing ischemic brain damage when conditioning before (preconditioning) and after (postconditioning) experimental stroke.
METHODS:
Hypothermia was induced in rats with a bolus of 6 mg/kg talipexole followed by 20 h continuous talipexole infusion of 6 mg/kg in total. Controls received similar treatment with saline. The core body temperature was continuously monitored. In preconditioning, hypothermia was terminated before either reversible occlusion of the middle cerebral artery (MCAO) for 60 min or global ischemia for 10 min with 2-vessel occlusion and hypotension. In postconditioning, rats experienced 60 min of MCAO before hypothermia was induced either immediately or with 3 h delay. Rats survived ischemia for 2, 7 or 90 days. Infarct volumes were quantified by stereology. Additional experiments of methodological relevance were included in the study.
RESULTS:
Talipexole induced mild hypothermia (35.1±1.1 to 36.0±0.5°C) for <20 h. Hypothermic pre- and postconditioning reduced infarct sizes by more than 60% as monitored during the first 90 days after experimental stroke (p<0.05).
CONCLUSION:
Talipexole is registered for use as a dopamine substitute in humans with Parkinson's disease. Although dosages cannot be directly translated to patients, our study exemplifies in an animal model that drug-induced hypothermia in a clinical setting might reduce cerebral ischemic damage before neuro- and cardiac surgical procedures and after stroke.
AuthorsFlemming F Johansen, Henrik Hasseldam, Rune S Rasmussen, Anne Sofie Bisgaard, Peter K Bonfils, Steen S Poulsen, Jacob Hansen-Schwartz
JournalPathobiology : journal of immunopathology, molecular and cellular biology (Pathobiology) Vol. 81 Issue 1 Pg. 42-52 ( 2014) ISSN: 1423-0291 [Electronic] Switzerland
PMID23989388 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 S. Karger AG, Basel.
Chemical References
  • Azepines
  • Dopamine Agonists
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • talipexole
Topics
  • Animals
  • Azepines (pharmacology)
  • Blotting, Western
  • Brain Ischemia (metabolism, pathology)
  • Disease Models, Animal
  • Dopamine Agonists (pharmacology)
  • Hypothermia, Induced (methods)
  • Ischemic Postconditioning (methods)
  • Ischemic Preconditioning (methods)
  • Rats
  • Vascular Endothelial Growth Factor A (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: